Cataracts, dry eyes, glaucoma and other eye problems become more common with age. But these can be treated — and sometimes ...

Knowing the risk factors of age-related macular degeneration (AMD) and consulting an ophthalmologist or optometrist can help ...

PRISM evaluates 4D-150, a potential backbone therapy designed to provide multi-year sustained delivery of anti-VEGF ...

D Molecular Therapeutics reported 52-week Phase 2b data for 4D-150 in wet AMD, showing sustained visual acuity improvements.

Charles Smith, who has age-related macular degeneration, has taken part in a series of trials over a 15-year period ...

Age-related macular degeneration (AMD) is an eye condition that occurs when the ... The cost for faricimab in 2022 was about $1,350 per injection. Most people don’t pay these amounts in full.

3E10 vg/eye showed an 83% reduction in injection ... with the goal of freeing patients from burdensome injections while preserving vision. About Wet AMD Wet AMD is a highly prevalent disease ...

Multiple subcutaneous doses safe and well-tolerated >69% reduction in anti-VEGF intravitreal (IVT) treatment burden in study eyes >67% ...

D Molecular Therapeutics (FDMT) announced positive initial interim 52-week data from the Phase 2b Population Extension cohort of the ...